CYP19A1 and cancer: GnRHa, aromatase inhibitors, progesterone, and ulipristal acetate may be a choice for treatment.[23,24] Combined with our case, the patient was diagnosed with low-grade malignant leiomyosarcoma and she refused another operation to remove her ovaries.